Literature DB >> 2913894

Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis.

A G Agusti1, J Roca, R Rodriguez-Roisin, R Mastai, P D Wagner, J Bosch.   

Abstract

We have recently shown that ventilation-perfusion (VA/Q) mismatching at rest in cirrhosis is due to an abnormal pulmonary vascular tone. It has been suggested that in patients with cirrhosis, O2 transfer might become diffusion-limited during exercise. This study examined pulmonary hemodynamics and mechanisms modulating gas exchange during exercise (60 to 70% VO2max) in six patients (41 +/- 5 yr, mean +/- SEM) with cirrhosis but with normal lung function tests. At rest, QT was high (8.4 +/- 0.5 L/min), pulmonary vascular resistance (PVR) was low (0.61 +/- 0.17 mm Hg/L/min), and there was mild to moderate VA/Q mismatching (LogSD Q, 0.79 +/- 0.09; normal range, 0.3 to 0.6). However, hyperventilation (PaCO2, 29 +/- 2 mm Hg) and high QT (thus, high PVO2, 41 +/- 2 mm Hg) contributed to the maintenance of PaO2 within normal values (99 +/- 7 mm Hg). Exercise VO2 (1,278 +/- 122 ml/min) was normal relative to work load, but, contrary to that in normal subjects, QT was higher and PVR did not fall. During exercise, PaO2 showed a trend to decrease (to 90 +/- 5 mm Hg) and PaCO2 to rise (to 35 +/- 2 mm Hg), but the differences failed to reach statistical significance (p = 0.07 each). PVO2 fell significantly with exercise (41 +/- 2 to 33 +/- 0.3 mm Hg, p less than 0.05), but neither AaPO2 (15 +/- 7 to 21 +/- 6 mm Hg) nor VA/Q inequality (LogSD Q, 0.82 +/- 0.11) changed. No systemic difference was noticed between predicted and measured PaO2 values, suggesting no O2 diffusion impairment during exercise.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2913894     DOI: 10.1164/ajrccm/139.2.485

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

3.  The cardiac response to exercise in cirrhosis.

Authors:  F Wong; N Girgrah; J Graba; Y Allidina; P Liu; L Blendis
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

4.  Hemodynamics in the immediate post-transplantation period in alcoholic and viral cirrhosis.

Authors:  Waleed K Al-Hamoudi; Saleh Alqahtani; Puneeta Tandon; Mang Ma; Samuel S Lee
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

5.  Analysis of impaired exercise capacity in patients with cirrhosis.

Authors:  S K Epstein; R L Ciubotaru; M D Zilberberg; L M Kaplan; C Jacoby; R Freeman; M M Kaplan
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

6.  Liver transplantation in adults: Choosing the appropriate timing.

Authors:  Maria Siciliano; Lucia Parlati; Federica Maldarelli; Massimo Rossi; Stefano Ginanni Corradini
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

Review 7.  Cardiovascular changes in cirrhosis: pathogenesis and clinical implications.

Authors:  Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

8.  Abnormal Gas Diffusing Capacity and Portosystemic Shunt in Patients With Chronic Liver Disease.

Authors:  Moon-Seung Park; Min-Ho Lee; Yoo-Sin Park; Shin-Hee Kim; Min-Jung Kwak; Ju-Seop Kang
Journal:  Gastroenterology Res       Date:  2012-09-20

9.  Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study.

Authors:  Nuria Mendoza; Eva Rivas; Roberto Rodriguez-Roisin; Tamara Garcia; Miquel Bruguera; Alvar Agusti; Rosa Faner
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

10.  Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.

Authors:  Orlando Luis de Andrade Santarém; Roberto de Cleva; Flávia Megumi Sasaya; Marianna Siqueira de Assumpção; Meive Santos Furtado; Alfonso Julio Guedes Barbato; Paulo Herman
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.